Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	22.53	38.34	19.84	52.42	45.63	59.44
Short-Term Investments	210.02	73.74	110.41	39.19	101	156.97
Cash & Short-Term Investments	232.56	112.08	130.25	91.61	146.63	216.41
Cash Growth	144.91%	-13.95%	42.18%	-37.52%	-32.25%	-21.03%
Accounts Receivable	0.91	-	0.04	0.94	0.34	1.23
Other Current Assets	3.34	3.42	3.5	4.41	7.24	6.85
Total Current Assets	236.81	115.5	133.79	96.97	154.2	224.49
Net Property, Plant & Equipment	2.87	3.35	2.72	3.94	7.18	10.73
Other Intangible Assets	-	-	-	-	-	29
Goodwill	-	-	-	-	-	12.64
Long-Term Investments	-	-	-	-	27.97	-
Other Long-Term Assets	0.31	0.31	0.31	0.89	1.7	6.39
Total Assets	240	119.17	136.82	101.79	191.06	283.25
Accounts Payable	1.68	0.59	0.46	2.49	2.66	4.6
Accrued Expenses	8.79	9.14	6.63	10.44	10.26	16.43
Current Portion of Leases	0.55	0.46	1.22	3.36	3.15	3.4
Unearned Revenue	42.36	37.62	30.92	-	-	-
Total Current Liabilities	53.38	47.8	39.23	16.3	16.07	24.43
Long-Term Leases	2.21	2.63	1.12	0.1	3.33	6.73
Other Long-Term Liabilities	1.72	35.38	55.38	2.73	2.73	11.52
Total Long-Term Liabilities	3.92	38.01	56.5	2.83	6.06	18.24
Total Liabilities	57.3	85.81	95.73	19.13	22.13	42.68
Common Stock	0.02	0.01	0.01	0	0.05	0.03
Additional Paid-in Capital	1,037	859.49	826.92	807.98	800.73	742.39
Accumulated Other Comprehensive Income	-0.09	-0.21	-0.08	-0.8	-0.42	-0.27
Retained Earnings	-854.14	-825.93	-785.75	-724.52	-631.43	-501.57
Shareholders' Equity	182.7	33.36	41.1	82.66	168.93	240.58
Total Liabilities & Equity	240	119.17	136.82	101.79	191.06	283.25
Total Debt	2.76	3.09	2.34	3.47	6.48	10.13
Net Cash (Debt)	229.8	108.99	127.91	88.15	140.15	206.28
Net Cash Growth	110.85%	-14.79%	45.11%	-37.11%	-32.06%	-21.20%
Net Cash Per Share	26.73	18.15	27.94	21.85	38.86	69.87
Book Value	182.7	33.36	41.1	82.66	168.93	240.58
Book Value Per Share	21.25	5.56	8.98	20.49	46.84	81.49
Tangible Book Value	182.7	33.36	41.1	82.66	168.93	198.94
Tangible Book Value Per Share	21.25	5.56	8.98	20.49	46.84	67.39

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q